Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amlodipine is an oral dihydropyridine calcium channel blocker used to treat high blood pressure (hypertension) and certain types of angina (chronic stable angina, vasospastic/variant angina), as well as to reduce the risk of hospitalization for angina and heart surgery in patients with coronary artery disease. It works by inhibiting voltage-dependent L-type calcium channels, primarily in vascular smooth muscle cells, leading to vasodilation and reduced peripheral vascular resistance. This lowers blood pressure and increases oxygen supply to the heart while reducing its workload. Amlodipine is available as tablets or oral solutions under several brand names[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amlodipine.